Mckesson (MCK) traded down -1.14 % during a 24 hours period ending at 07:22 PM Central Europe on Monday 26th. One Mckesson stock can currently be bought for about USD 991.4 on popular exchanges. Current supply of Mckesson stocks is 116.6 mn. Mckesson has a current market capitalization of USD 116.7 bn and approximately USD 629.5 mn worth of Mckesson was traded on exchanges in the last 24 hours. Since last month end, Mckesson has traded 15.12 % up. Simple moving average of last 200 days is at USD 858.72. The highest price of past 52 weeks was recorded at USD 1,030.27 on 10/20/2026. 52 weeks low was at USD 723.68 on 05/11/2026.
Here is how related stocks have performed in the past 24 hours:
Progressive (PGR) traded down -0.68 % and now trades at USD 228.41. Progressive has a market capitalisation of USD 132.2 bn. Progressive has a current price to earnings ratio of 11.48.
Western Digital (WDC) traded down -2.97 % and now trades at USD 360.73. Current market capitalisation for Western Digital is USD 128.6 bn. Western Digital has a current price to earnings ratio of 14.08. Western Digital’s shares continued to face pressure despite a strong reporting period, with the company surpassing analyst forecasts for both revenue and earnings and offering a robust outlook. Nonetheless, the stock slipped more than nine percent over two trading days and finished the week near its previous level. Investors remain uncertain about the market’s reaction to the company’s positive financials, even as Western Digital benefits from growth in artificial‑intelligence data‑center deployments. Meanwhile, the firm joined a broader group of issuers that have objected to the tokenisation of their shares on a new blockchain‑based trading platform. The objections were filed under recent U.S. Securities and Exchange Commission rules that allow companies a 30‑day period to decline third‑party tokenised listings. This stance adds to a growing wave of resistance among major technology and financial institutions, potentially affecting the scope of the platform’s initial offering.
Uber (UBER) traded down -3.43 % and now trades at USD 65.96. Current market capitalisation for Uber is USD 136.2 bn. Uber has a current price to earnings ratio of 14.61.
Bristol-myers Squibb (BMY) traded down -2.41 % and now trades at USD 61.4. Bristol-myers Squibb has a market capitalisation of USD 125.6 bn. Bristol-myers Squibb has a current price to earnings ratio of 13.57. Bristol‑Myers Squibb reported that its bispecific antibody‑drug conjugate, izalontamab brengitecan (Iza‑Bren), demonstrated a marked improvement in progression‑free survival compared with standard chemotherapy in a phase‑III study of patients with previously‑treated, EGFR‑mutated non‑small‑cell lung cancer. The late‑breaking results will be presented at the European Society for Medical Oncology conference and subsequently published in The Lancet. In a related development, the company’s partnership with BioNTech yielded encouraging phase‑II data for the bispecific immunomodulator pumitamig in combination with docetaxel, showing a favorable response rate and progression‑free survival in patients whose disease had progressed after first‑line immunotherapy plus chemotherapy. Both programmes highlight Bristol‑Myers Squibb’s continued focus on expanding treatment options for lung‑cancer patients with limited alternatives.
Vertex (VRTX) traded down -2.1 % and now trades at USD 514.77. Vertex has a market capitalisation of USD 132.8 bn. Vertex has a current price to earnings ratio of 30.63. Vertex Pharmaceuticals Inc. has experienced a notable decline in its share price following the recent unlock of a substantial portion of its restricted holdings. The company’s stock fell sharply, reaching new lows that reflected a significant drop from earlier highs, and the market reaction has been largely negative. In response to investor concern, Vertex’s executive team announced a voluntary extension of their own lock‑up period, postponing the sale of a large block of shares for an additional twelve months. This move aims to stabilise the market and mitigate potential volatility. Overall, the company’s latest trading activity has highlighted sensitivity to liquidity changes and has prompted management to take steps to reassure shareholders.
About Mckesson
The McKesson Corporation is a distribution company based in Irving, Texas, United States. It specializes in supplying pharmaceuticals, medical-surgical supplies, and health and beauty care products throughout North America. Additionally, the company develops, implements, and supports software that aids in integrating data within the health enterprise. Furthermore, McKesson offers analytic, care management, and patient solutions for payers. You can find more information about the company and its activities on its website at www.mckesson.com . The company’s stock is traded on the New York Stock Exchange.
